19692-3 |
Secobarbital |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Secobarbital [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19692-3 |
|
Screen |
|
|
Both |
|
|
|
0 |
Secobarbital Ur Ql Scn |
|
|
|
|
|
Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Secobarb; Seconal; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19695-6 |
Secobarbital |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Secobarbital [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19695-6 |
|
|
|
|
Both |
|
|
|
0 |
Secobarbital Ur-mCnc |
|
|
|
Y |
|
Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Secobarb; Seconal; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
19696-4 |
Secobarbital cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Secobarbital cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19696-4 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Secobarbital CtO Ur Scn-mCnc |
|
|
|
Y |
|
Barbiturate; CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Secobarb; Seconal; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19697-2 |
Secobarbital cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Secobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19697-2 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Secobarbital CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Secobarb; Seconal; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19698-0 |
Temazepam |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Temazepam [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19698-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Temazepam Ur Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Normison; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Restoril; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
197-4 |
Cloxacillin |
Susc |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
197-4 |
|
MIC |
|
|
Observation |
|
|
|
0 |
Cloxacillin Islt MIC |
|
|
|
|
|
Alclox; Ampiclox; Amplium; ANTIBIOTIC SUSCEPTIBILITIES; APO-CLOXI; AST; Austrastaph; Clocillin; Cloxin; Ekvacillin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Novo-cloxi; Nu-cloxi; Orbenin; Penstapho n; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tegopen |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
1970-3 |
Bilirubin.albumin bound |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bilirubin.delta [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
1970-3 |
|
|
|
|
Both |
|
|
|
0 |
Bilirub Delta SerPl-mCnc |
|
|
|
Y |
|
Alb; Associated; Bili; Bili.delta; Bili-alb; Bilirub Delta; Bilirubins; Billirubin; bnd; Chemistry; DELB; Delta bilirubin; Deltab; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL; TBIL-(Bu+Bc) |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
19700-4 |
Temazepam cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Temazepam cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19700-4 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Temazepam CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; Scn; Scr; Scrn; UA; UR; Urn |
2.42 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19701-2 |
Temazepam cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Temazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19701-2 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Temazepam CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19702-0 |
Tetrahydrocannabinol |
ACnc |
Urine |
Pt |
Ord |
Screen |
|
DEPRECATED |
Deprecated Tetrahydrocannabinol [Presence] in Urine by Screen method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19702-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Deprecated THC Ur Ql Scn |
|
|
|
|
|
Arbitrary concentration; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Marijuana; Nabilone; Ordinal; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19703-8 |
Tetrahydrocannabinol |
ACnc |
Urine |
Pt |
Ord |
Confirm |
|
DEPRECATED |
Deprecated Tetrahydrocannabinol [Presence] in Urine by Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19703-8 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Deprecated THC Ur Ql Cfm |
|
|
|
|
|
Arbitrary concentration; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Marijuana; Nabilone; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; THC; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19704-6 |
Tetrahydrocannabinol cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
DEPRECATED |
Deprecated Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19704-6 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Deprecated THC CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Level; Marijuana; Mass concentration; Nabilone; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; THC; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19705-3 |
Tetrahydrocannabinol cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
DEPRECATED |
Deprecated Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19705-3 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Deprecated THC CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Marijuana; Mass concentration; Nabilone; Point in time; QNT; Quan; Quant; Quantitative; Random; THC; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19706-1 |
Thioridazine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Thioridazine [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19706-1 |
|
Screen |
|
|
Both |
|
|
|
0 |
Thioridazine Ur Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Mellaril; Novo-ridazine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sonapax; Thioridazine Hydrochloride; Thioril; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19707-9 |
Thioridazine |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Thioridazine [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19707-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Thioridazine Ur Ql Cfm |
|
|
|
|
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Mellaril; Novo-ridazine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sonapax; Thioridazine Hydrochloride; Thioril; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19708-7 |
Thioridazine cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Thioridazine cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19708-7 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Thioridazine CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mellaril; Novo-ridazine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Sonapax; Thioridazine Hydrochloride; Thioril; UA; UR; Urn |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
19709-5 |
Thioridazine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Thioridazine cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19709-5 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Thioridazine CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Mellaril; Novo-ridazine; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonapax; Thioridazine Hydrochloride; Thioril; UA; UR; Urn |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
1971-1 |
Bilirubin.non-glucuronidated |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bilirubin.indirect [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
1971-1 |
|
|
|
|
Both |
|
|
|
0 |
Bilirub Indirect SerPl-mCnc |
|
|
|
Y |
|
Bili; Bilirub Indirect; Bilirubin indirect; Bilirubin non-conjugated; Bilirubin primary; Bilirubin unconjugated; Bilirubins; Billirubin; Bu; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
19710-3 |
traMADol |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
traMADol [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19710-3 |
|
Screen |
|
|
Both |
|
|
|
0 |
traMADol Ur Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tramal; UA; Ultram; UniversalLabOrders; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19712-9 |
traMADol cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
traMADol cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19712-9 |
|
Screen |
|
|
Observation |
|
|
|
0 |
traMADol CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Tramal; UA; Ultram; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19713-7 |
traMADol cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
traMADol cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19713-7 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
traMADol CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramal; UA; Ultram; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19714-5 |
Triazolam |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Triazolam [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19714-5 |
|
Screen |
|
|
Both |
|
|
|
0 |
Triazolam Ur Ql Scn |
|
|
|
|
|
APO-TRIAZO; DRUG/TOXICOLOGY; Drugs; Halcion; Novo-triolam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19716-0 |
Triazolam cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Triazolam cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19716-0 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Triazolam CtO Ur Scn-mCnc |
|
|
|
Y |
|
APO-TRIAZO; CtO; DRUG/TOXICOLOGY; Drugs; Halcion; Level; Mass concentration; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.42 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19717-8 |
Triazolam cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Triazolam cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19717-8 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Triazolam CtO Ur Cfm-mCnc |
|
|
|
Y |
|
APO-TRIAZO; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Halcion; LC/MS/MS; Level; Mass concentration; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19718-6 |
Trichlorothiazide |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Trichlorothiazide [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19718-6 |
|
Screen |
|
|
Both |
|
|
|
0 |
TCT Ur Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; TCT; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |